Results 1 to 10 of about 9,989,625 (302)

Neonatal Clinical Pharmacology [PDF]

Children
Similar to other populations, care of neonates strongly relies on robust guidance on neonatal pharmacotherapy, covering an age-appropriate drug formulation, an individualized dose, and information on its efficacy and safety for a specific indication in ...
Karel Allegaert, Nadir Yalcin, Robert B. Flint, Sinno H. P. Simons   +3 more
doaj   +4 more sources

Flupirtine : Clinical pharmacology

Journal of Anaesthesiology Clinical Pharmacology, 2012
Flupirtine is neither an opioid nor a non steroidal anti-inflammatory drug (NSAID) producing its analgesic action through blockade of glutamate N-methyl-D-aspartate receptor.
S Harish, K Bhuvana, Girish M Bengalorkar, T N Kumar   +3 more
doaj   +4 more sources

Clinical pharmacology [PDF]

Zdravniški Vestnik, 2006
Backgrounds: Clinical pharmacology has developed in the second half of 20th century and is now part of an undergraduate and postgraduate studies, being taught as a separate subject on most universities in developed countries.
Jože Drinovec
doaj   +2 more sources

Clinical pharmacology: Developmental path, regulations, education, practical management: Generally and in Serbia [PDF]

Hospital Pharmacology, 2022
Introduction: After searching literature, Professor of Pharmacology at Cornell University Harry Gold was the first to use the name Clinical Pharmacology in the late 1930s and early 1940s.
Kastratović Dragana A., Marković Srđan Z., Slobodan Janković M.   +2 more
doaj   +1 more source

Clinical Pharmacology [PDF]

, 2007
和田 努, 恒枝 宏史, 笹岡 利安
core   +13 more sources

Fospropofol: Clinical Pharmacology

Journal of Anaesthesiology Clinical Pharmacology, 2011
Girish M Bengalorkar, K Bhuvana, N Sarala, T N Kumar   +3 more
doaj   +3 more sources

Educating Medical Students on How to Prescribe Anti-Hyperglycaemic Drugs: A Practical Guide

Diabetology, 2023
In the light of the rapidly increasing global incidence of, and therapeutic arsenal for, diabetes type 2, this brief report underscores the need for advancements in clinical pharmacology and therapeutics (CPT) education with regard to diabetes type 2. We
Erik M. Donker, Andrej Belančić, Joost D. Piët, Dinko Vitezić, Jelle Tichelaar, on behalf of the Clinical Pharmacology and Therapeutics Teach the Teacher (CP4T) Program and the Early Career Pharmacologists of the European Association for Clinical Pharmacology and Therapeutics (EACPT)   +5 more
doaj   +1 more source

Clinical Pharmacology of RNA Interference–Based Therapeutics: A Summary Based on Food and Drug Administration–Approved Small Interfering RNAs

Drug Metabolism And Disposition, 2022
RNA-based oligonucleotide therapeutics are revolutionizing drug development for disease treatment. This class of therapeutics differs from small molecules and protein therapeutics in various ways, including both its mechanism of action and clinical ...
Xing Jing, V. Arya, K. Reynolds, Hobart L Rogers   +3 more
semanticscholar   +1 more source

Current pharmacotherapy of osteoporosis and its future [PDF]

Farmacja Polska, 2021
Osteoporosis is a systemic bone disease characterised by loss of bone mass and abnormal remodelling of the micro-architecture of bone tissue. Worldwide, it is estimated that more than 200 million people suffer from this disease. In Poland, there were 2.1
Arnold Kukowka, Mariusz Pluskota, Maciej Arciszewski, Tomasz Sroczyński   +3 more
doaj   +1 more source

Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials

Clinical Pharmacokinetics, 2021
The absorption, distribution and elimination of oral semaglutide, the first oral glucagon-like peptide-1 receptor agonist for treating type 2 diabetes, was investigated using a population pharmacokinetic model based on data from clinical pharmacology ...
R. V. Overgaard, A. Navarria, S. Ingwersen, T. Bækdal, R. J. Kildemoes   +4 more
semanticscholar   +1 more source